ro co tirzepatide Eli Lilly strikes Zepbound deal

NextStep Takeaways for Clinicians & Organizations Adopt GLP1 onboarding pathways to ensure first-month check-ins

These cardiovascular benefits have influenced treatment algorithms, with guidelines recommending GLP-1 receptor agonists with proven cardiovascular benefit for patients with type 2 diabetes and atherosclerotic cardiovascular disease

Reports of patients with diabetes experiencing supply shortages of their medication indicate they are frustrated more with prescribers recommending it and pharmacies overselling it, rather than other people purchasing it

Step 5: Communicate Side Effects Immediately

doi: 10.1111/j.1440-1754.2011.02225.x 7 McAllisterCJWhittingtonJEHollandAJ